Slow progression of juvenile metachromatic leukodystrophy 6 years after bone marrow transplantation.
Metachromatic leukodystrophy refers to a group of genetic neurologic diseases caused by deficiencies of the enzyme arylsulfatase A and the resulting accumulation of sulfatides in white matter. Bone marrow transplantation has been advocated as a treatment in an attempt to correct the enzyme deficiency. Such a transplant was performed in 1991 in a 16-year-old girl with a form of late juvenile metachromatic leukodystrophy caused by a homozygous P426L mutation in the arylsulfatase A gene. Engraftment was prompt and resulted in constant enzymatic normalization of circulating lymphocytes. The elevated urinary excretion of sulfatides remained unaffected. Clinical findings up until transplantation consisted of gait disturbances, impairment of cognitive functioning, and deterioration in school performance over several years. During a 6-year follow-up period, the patient's condition was subject to major fluctuations but, on the whole, findings showed slow neurologic and neurophysiologic deterioration. The clinical course observed after bone marrow transplantation probably more or less reflects the natural course expected in this form of late-onset metachromatic leukodystrophy.
Kapaun
P
P
Department of Pediatrics, University of Hamburg, Germany.
Dittmann
R W
RW
Granitzny
B
B
Eickhoff
W
W
Wulbrand
H
H
Neumaier-Probst
E
E
Zander
A
A
Kohlschüetter
A
A
D000293:Adolescent; D016026:Bone Marrow Transplantation; D018450:Disease Progression; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D007966:Leukodystrophy, Metachromatic / Q000175:diagnosis* / Q000188:drug therapy / Q000601:surgery*; D009483:Neuropsychological Tests; D016896:Treatment Outcome